Worldwide Embolization Particle market is valued at 1170 million US$ in 2018 is expected to reach 3240 million US$ by the end of 2025, growing at a CAGR of 13.6% during 2019-2025 | Industry Leaders Covered | Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon|
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.
In the industry, Sirtex Medical profits most in 2016 and recent years, while Merit Medical and BTG Medical ranked 2 and 3.The market share of them is 23.11%, 17.44% and 14.53% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are four mainly types of Embolization Particle, including Microspheres, Particles, DEBs and Radio-Embolic Microspheres. And Microspheres is the main type for Embolization Particle, and the Microspheres reached a sales value of approximately 347.54 M USD in 2016, with 34.55% of global sales volume.
The global Embolization Particle market is valued at 1170 million US$ in 2018 is expected to reach 3240 million US$ by the end of 2025, growing at a CAGR of 13.6% during 2019-2025.
This report focuses on Embolization Particle volume and value at global level, regional level and company level. From a global perspective, this report represents overall Embolization Particle market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The report includes an in-depth analysis of the competitive landscape of this business vertical, constituting manufacturers like:
Boston Scientific Corporation
INterface BIOmaterials B.V.
Market Segment by Regions includes:
Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
By Industrial Application, the market can be split into:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Global Embolization Particle Market Research Report 2019 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2019 through 2025. Also, a five-year historic analysis is provided for these markets in this 94 pages report.
This market report provides in-depth analytics of the Embolization Particle industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.
Trusted Business Insights
Blogger & Influencer Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580